Scanning Medical Journals
No new significant updates or guidelines matching this topic were found today. We will check again soon.
Revised IPI (R-IPI): Recalibrated for patients receiving Rituximab (R-CHOP). Identifies a "Very Good" group with exceptional survival.
R-IPI Prediction
Estimated 4-y OS
Verified
Last Review: 2026
Last Comprehensive Review: 2026
